Removing Barriers to Allergy Diagnostic Testing Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 1, 2019)
Removing Barriers to Allergy Diagnostic Testing Act of 2019
This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.
Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
What just happenedApr 2, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 1, 2019
- Apr 2, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 1, 2019Committee
Referred to the Subcommittee on Health.
Ways and Means CommitteeHealth Subcommittee - Apr 1, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 1, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 1, 2019IntroReferralIntro-H
Introduced in House
- Apr 1, 2019IntroReferral1000
Introduced in House